MMP9 and breast carcinoma: More broadly, contemporary syntheses of the MMP field in breast cancer and chemoresistance emphasize that MMP network activation (including MMP-9) is enriched in aggressive or antiestrogen-resistant states—even if the specific MMP driver varies by model—underscoring a plausible mechanistic link between tamoxifen pressure and protease-enabled invasion [131].